GPR34 and lymphoplasmacytic lymphoma: While GPR34 translocations and GOF mutations are enriched in SG cases (Moody et al., 2018), GPR34 expression is generally increased in MALT, MZB, and lymphoplasmacytic lymphomas (Ansell et al., 2012), suggesting a broader pathological relevance of the receptor.